RecruitingPhase 3NCT06624592

Sevoflurane/Dexmedetomidine vs. Isoflurane for Pediatric Emergence Delirium

Sevoflurane/Dexmedetomidine vs. Isoflurane and Their Effects on Pediatric Emergence Delirium

Sponsor

Mayo Clinic

Enrollment

400 participants

Start Date

Dec 20, 2024

Study Type

INTERVENTIONAL

Conditions

Delirium on Emergence

Summary

The purpose of this study is to measure the incidences of pediatric emergence delirium between the group receiving Isoflurane and the group receiving Sevoflurane plus intravenous push dexmedetomidine.

Eligibility

Min Age: 2 YearsMax Age: 7 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Isoflurane and a drug called Sevoflurane for people with delirium on emergence. The study is currently recruiting participants at 1 location. People eligible for this study include aged 2 Years to 7 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGSevoflurane

Subjects will receive standard of care anesthesia Sevoflurane, with intravenous push Dexmedetomidine

DRUGIsoflurane

Subjects will receive standard of care anesthesia Isoflurane

Locations(1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06624592